Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Hui-Su Lim

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
JCO Global Oncology|May 23, 2024
The Road Less Traveled: Perspective From an Australian OncologistStephanie Hui-Su Lim
Pathology|June 11, 2025
Oncogenic mutations of clinical significance in colorectal cancerVivienne Lea, Stephanie Hui-Su Lim, Cheok Soon Lee
Cancer Treatment Reviews|June 1, 2014
Systemic therapy in neurofibromatosis type 2Stephanie Hui-Su Lim, Simone Ardern-Holmes, Geoffrey McCowage, et al.
Case Reports in Oncological Medicine|December 26, 2013
Takotsubo cardiomyopathy and 5-Fluorouracil: getting to the heart of the matterStephanie Hui-Su Lim, Sharon Mary Wilson, Arnagretta Hunter, et al.
Journal of Clinical Pathology|March 23, 2021
Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancerKate Wilkinson, Weng Ng, Tara Laurine Roberts, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 29, 2026
Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line settingRebecca Han Nguyen, Joanne Tang, Udit Nindra, et al.
Cancers|August 31, 2019
Health-Related Quality of Life during Chemoradiation in Locally Advanced Rectal Cancer: Impacts and Ethnic DisparitiesStephanie Hui-Su Lim, Emilia Ip, Weng Ng, et al.
International Journal of Molecular Sciences|August 29, 2024
The Prognostic and Predictive Utility of CDX2 in Colorectal CancerWei Yen Chan, Wei Chua, Kate Wilkinson, et al.
Molecular and Clinical Oncology|October 29, 2021
Rectal cancer treatment and outcomes in elderly patients treated with curative intentSharlyn Kang, Kate J Wilkinson, Daniel Brungs, et al.
Clinical Colorectal Cancer|May 24, 2025
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal CancerJane McKenzie, Vanessa Wong, Shehara Mendis, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
JCO Global Oncology|May 23, 2024
The Road Less Traveled: Perspective From an Australian OncologistStephanie Hui-Su Lim
Pathology|June 11, 2025
Oncogenic mutations of clinical significance in colorectal cancerVivienne Lea, Stephanie Hui-Su Lim, Cheok Soon Lee
Cancer Treatment Reviews|June 1, 2014
Systemic therapy in neurofibromatosis type 2Stephanie Hui-Su Lim, Simone Ardern-Holmes, Geoffrey McCowage, et al.
Case Reports in Oncological Medicine|December 26, 2013
Takotsubo cardiomyopathy and 5-Fluorouracil: getting to the heart of the matterStephanie Hui-Su Lim, Sharon Mary Wilson, Arnagretta Hunter, et al.
Journal of Clinical Pathology|March 23, 2021
Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancerKate Wilkinson, Weng Ng, Tara Laurine Roberts, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 29, 2026
Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line settingRebecca Han Nguyen, Joanne Tang, Udit Nindra, et al.
Cancers|August 31, 2019
Health-Related Quality of Life during Chemoradiation in Locally Advanced Rectal Cancer: Impacts and Ethnic DisparitiesStephanie Hui-Su Lim, Emilia Ip, Weng Ng, et al.
International Journal of Molecular Sciences|August 29, 2024
The Prognostic and Predictive Utility of CDX2 in Colorectal CancerWei Yen Chan, Wei Chua, Kate Wilkinson, et al.
Molecular and Clinical Oncology|October 29, 2021
Rectal cancer treatment and outcomes in elderly patients treated with curative intentSharlyn Kang, Kate J Wilkinson, Daniel Brungs, et al.
Clinical Colorectal Cancer|May 24, 2025
Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal CancerJane McKenzie, Vanessa Wong, Shehara Mendis, et al.
Pageof 2